NodeAI Diagnostics

Seed
nodeai.ca AI & Machine Learning Hamilton, Canada
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced May 11, 2026
Investors Undisclosed
Decision Makers 1 Verified

About NodeAI Diagnostics

NodeAI Diagnostics develops AI-driven tools to improve lung cancer staging by enhancing ultrasound analysis during biopsies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Seed
Global Headquarters Hamilton, Canada
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website nodeai.ca
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for NodeAI Diagnostics.

Funding History

1 Round
Seed · May 11, 2026
Undisclosed

Founders & Leadership

2

Anthony Gatti

Founder

Work email & phone locked Unlock →

MacKensey Bacon

Founder

Work email & phone locked Unlock →

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts